Blog

Joris van de Haar: We characterize the microbial DNA in metastatic cancers with unprecedented accuracy, breath and depth

Photo from Joris van de Haar/X

Apr 13, 2024, 08:20

Joris van de Haar: We characterize the microbial DNA in metastatic cancers with unprecedented accuracy, breath and depth

Joris van de Haar, Translational Research and Precision Medicine Working Group at ESMO, shared a post by Cell, on X/Twitter:

“Thrilled that it is out now!
Led by the talented Thomas Battaglia and Iris Mimpen.
While addressing key technical limitations of previous work, we characterize the microbial DNA in metastatic cancers with unprecedented accuracy, breath and depth. Read the paper to learn more!
Great team effort with Lodewyk Wessels, Emile Voest, and many others!
At The Netherlands Cancer Institute, Oncode Institute. With data of Hartwig Medical.”

Quoting Cell’s post:

“Now online! A pan-cancer analysis of the microbiome in metastatic cancer.”

Source: Joris van de Haar/X and Cell/X

cancer Emile Voest Hartwig Medical Iris Mimpen Joris van de Haar Lodewyk Wessels metastatic cancers microbial DNA OncoDaily Oncode Institute Oncology Pan-cancer analysis The Netherlands Cancer Institute Thomas Battaglia

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers